Premier Alternatives

Ascend (Drug Discovery)

Rockville, MD · Founded 2021 · Privately Held (backing)

Developer of a biotechnology platform designed to support the development and commercialization of advanced therapies. Ascend (Drug Discovery) is based in Rockville, MD and was founded in 2021. Its last known valuation is $151 million. It has raised $194 million.

Last price · $/share
—
Implied valuation
$150.9M
Total raised
$194.3M
Last round
—

Ascend (Drug Discovery) key facts

  • Developer of a biotechnology platform designed to support the development and commercialization of advanced therapies.
  • Ascend (Drug Discovery)’s last known valuation is $150.9M.
  • It has raised $194.3M; the latest was Early Stage VC ($42.5M) in Nov 2024.
  • Notable investors include DCVC, Cathay Capital, Digitalis Ventures, Deerfield Management, DCVC Bio — 13 tracked in total.
  • Status: Privately Held (backing).
Free account
More of Ascend (Drug Discovery) with a free account
  • ·The complete investor list: 13 names
  • ·Watch Ascend (Drug Discovery): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Ascend (Drug Discovery) funding rounds

No rounds on record

No funding rounds for Ascend (Drug Discovery) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Ascend (Drug Discovery) valuation

Ascend (Drug Discovery)'s last known valuation is $151 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

Ascend (Drug Discovery) investors

13 investors are on record for Ascend (Drug Discovery), including DCVC, Cathay Capital, Digitalis Ventures and Deerfield Management. By type, the record holds 5 venture capital firms, 1 hedge fund and 1 private equity firm.

About Ascend (Drug Discovery)

Developer of a biotechnology platform designed to support the development and commercialization of advanced therapies. The company provides process development, manufacturing, and regulatory expertise from research to clinical and commercial scale, enabling biotechnology teams to integrate scalable manufacturing into their operations from the beginning.

Sector
Healthcare
HQ
Rockville, MD, United States
Founded
2021
Employees
128
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.

Valuation on record
$150.9M

Ascend (Drug Discovery)’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.